Lior Raviv

Chief Technology Officer • Pluristem Therapeutics Inc.

Lior Raviv joined Pluristem in 2011 and currently serves as Chief Technology Officer. Prior to that, Mr Raviv served as Projects manager & Product development Team leader at Pluristem in charge of new technologies and process development. Prior to joining Pluristem and during the years 2010-2011, Mr Raviv held the position of R&D Analytical Researcher at Teva Pharmaceutical Industries. Mr Raviv holds an M.Med.Sec in pharmacology from Ben Gurion University and a B.S.c in Biotechnology Engineering from Ben Gurion University.

Also speaking

Tobias Brandt

Senior Scientist, Viral Vector Process Development • CSL Behring

Laura Herbst

Research Fellow • Fraunhofer

Stuart Curbishley

Chief Manufacturing and Development Officer • Adthera Bio

Event Info


Event Brochure

Take a look at the 2023 Event Brochure for Advanced Therapies Europe.

Download the 2023 Speaker List

Download the 2023 Speaker List for Advanced Therapies Europe here.